A Study of Sipuleucel-T With Administration of Enzalutamide in Men With Metastatic Castrate-Resistant Prostate Cancer
Status:
Completed
Trial end date:
2017-06-30
Target enrollment:
Participant gender:
Summary
This is a randomized, open-label study designed to assess the effects of sipuleucel-T when
administered concurrently or sequentially with enzalutamide.